
|Articles|June 15, 2011
Julian Upton
<>
Advertisement
Julian Upton serves as European Editor for Pharm Exec and as Editor of its digital sister publication, Pharm Exec Global Digest. Julian first joined Advanstar Communications in 1998 and has worked in various editorial capacities for the company. Outside Advanstar, he has edited business magazines on topics ranging from healthcare to finance and defence.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Foundayo Under National Priority Voucher Program
2
Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals
3
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
4
Being Specific About Being General: Vaccines Edition
5




